Xyntha is a Kit in the Plasma Derivative category. It is labeled and distributed by Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc. The primary component is .
| Product ID | 58394-023_0c8fa547-161b-40d8-89a7-5ca96474743d |
| NDC | 58394-023 |
| Product Type | Plasma Derivative |
| Proprietary Name | Xyntha |
| Generic Name | Antihemophilic Factor (recombinant) |
| Dosage Form | Kit |
| Marketing Start Date | 2011-12-01 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125264 |
| Labeler Name | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2011-12-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA125264 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | EA |
| Marketing Start Date | 2011-12-01 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 58394-014 | Xyntha | Xyntha |
| 58394-015 | Xyntha | Xyntha |
| 58394-022 | Xyntha | Xyntha |
| 58394-024 | Xyntha | Xyntha |
| 58394-013 | Xyntha | Xyntha |
| 58394-012 | Xyntha | Xyntha |
| 58394-016 | Xyntha | Xyntha |
| 58394-023 | Xyntha | Xyntha |
| 58394-025 | Xyntha | Xyntha |
| 0026-3782 | Kogenate FS | Antihemophilic Factor (Recombinant) |
| 0026-3783 | Kogenate FS | Antihemophilic Factor (Recombinant) |
| 0026-3785 | Kogenate FS | Antihemophilic Factor (Recombinant) |
| 0026-3786 | Kogenate FS | Antihemophilic Factor (Recombinant) |
| 0026-3787 | Kogenate FS | Antihemophilic Factor (Recombinant) |
| 0026-3821 | Kovaltry | Antihemophilic Factor (Recombinant) |
| 0026-3822 | Kovaltry | Antihemophilic Factor (Recombinant) |
| 0026-3824 | Kovaltry | Antihemophilic Factor (Recombinant) |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() XYNTHA 78754885 3535448 Live/Registered |
WYETH LLC 2005-11-16 |
![]() XYNTHA 77380592 3607161 Live/Registered |
WYETH LLC 2008-01-25 |